Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 1

Interventions

3-ingenyl angelate 11Photochemotherapy 7Aminolevulinic Acid 7Imiquimod 6methyl 5-aminolevulinate 5Fluorouracil 5Gels 4Diclofenac 4Cryotherapy 3BF-200 ALA 3tirbanibulin 2Therapeutics 2Solutions 2green tea extract polyphenone E 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1Ointments 1LEO 43204 1Drugs, Generic 1Deoxyribonuclease (Pyrimidine Dimer) 1Cryosurgery 1Cosmetics 15-fluorouracil, salicylic acid drug combination 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Keratosis, Actinic × 5-fluorouracil, salicylic acid drug combination × Clear all
NCT02289768 2016-08-05

Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses

Almirall, S.A.

Phase 3 Completed
166 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡